Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Guangdong Kanghua Healthcare Co., Ltd. Class H ( (HK:3689) ) just unveiled an announcement.
Guangdong Kanghua Healthcare Group has agreed to sell its remaining 45% equity stake in Chongqing-based Kangxin Hospital to Beijing Fazheng Industrial Group for an estimated RMB14.2 million. After completion, Kangxin Hospital will no longer be accounted for as an associate, but Kanghua will retain full ownership of the underlying land and buildings through a property subsidiary and continue leasing them to the hospital.
The board cited Kangxin Hospital’s continued underperformance and intensifying competition in the Chongqing healthcare market as key reasons for the exit, arguing that further capital injections would not be in the best interests of the group or its shareholders. The disposal, classified as a discloseable transaction under Hong Kong listing rules, is intended to optimize resource allocation and realign the group’s strategic priorities toward more sustainable long-term development without requiring shareholder approval.
The most recent analyst rating on (HK:3689) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Guangdong Kanghua Healthcare Co., Ltd. Class H stock, see the HK:3689 Stock Forecast page.
More about Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Group Co., Ltd. is a PRC-based healthcare group operating hospitals and related medical facilities. The company focuses on providing clinical and inpatient services in regional markets such as Chongqing, while also holding and leasing medical property assets used in its healthcare operations.
Average Trading Volume: 9,048
Technical Sentiment Signal: Buy
Current Market Cap: HK$698.9M
See more data about 3689 stock on TipRanks’ Stock Analysis page.